uk-390,957
Small moleculeexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
4
Phase 4
0
Earliest trial started Aug 1, 2004 (NCT00143117)
Timeline
2000s
- Jan 1, 2004
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Serotonin transporterINHIBITOR
SLC6A4 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- uk-390,957
- uk-390,957
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00219609 | Phase 2/Phase 3 (Phase 3) | Jan 1, 2005 | Pfizer |
| NCT00219635 | Phase 2/Phase 3 (Phase 3) | Jan 1, 2005 | Pfizer |
| NCT00143117 | Phase 2/Phase 3 (Phase 3) | Aug 1, 2004 | Pfizer |
| NCT00219583 | Phase 2/Phase 3 (Phase 3) | Aug 1, 2004 | Pfizer |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Pfizer | For profit | 4 | 4 | 1 | 2004 |
1 organizations
Page 1 / 1